Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 26530011)

  • 1. EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.
    Ma J; Nie K; Redmond D; Liu Y; Elemento O; Knowles DM; Tam W
    Leukemia; 2016 Mar; 30(3):594-604. PubMed ID: 26530011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EBV microRNA-BHRF1-2-5p targets the 3'UTR of immune checkpoint ligands PD-L1 and PD-L2.
    Cristino AS; Nourse J; West RA; Sabdia MB; Law SC; Gunawardana J; Vari F; Mujaj S; Thillaiyampalam G; Snell C; Gough M; Keane C; Gandhi MK
    Blood; 2019 Dec; 134(25):2261-2270. PubMed ID: 31856276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.
    Ayoubian H; Ludwig N; Fehlmann T; Menegatti J; Gröger L; Anastasiadou E; Trivedi P; Keller A; Meese E; Grässer FA
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Epstein-Barr Virus MicroRNA Blocks Interleukin-1 (IL-1) Signaling by Targeting IL-1 Receptor 1.
    Skinner CM; Ivanov NS; Barr SA; Chen Y; Skalsky RL
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1.
    Song Y; Li X; Zeng Z; Li Q; Gong Z; Liao Q; Li X; Chen P; Xiang B; Zhang W; Xiong F; Zhou Y; Zhou M; Ma J; Li Y; Chen X; Li G; Xiong W
    Oncotarget; 2016 Jun; 7(24):36783-36799. PubMed ID: 27167345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBV-miR-BHRF1-1 Targets p53 Gene: Potential Role in Epstein-Barr Virus Associated Chronic Lymphocytic Leukemia.
    Xu DM; Kong YL; Wang L; Zhu HY; Wu JZ; Xia Y; Li Y; Qin SC; Fan L; Li JY; Liang JH; Xu W
    Cancer Res Treat; 2020 Apr; 52(2):492-504. PubMed ID: 31671936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of the expression of the Epstein-Barr virus (EBV) anti-apoptotic gene BHRF1 in nasopharyngeal carcinoma and EBV-related lymphoid diseases.
    Nicholls J; Kremmer E; Meseda CA; Mackett M; Hahn P; Gulley ML; Brink A; Swinnen LJ; Greenspan J; De Souza Y; Grässer F; Sham J; Ng MH; Arrand JR
    J Med Virol; 2001 Sep; 65(1):105-13. PubMed ID: 11505451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma.
    Imig J; Motsch N; Zhu JY; Barth S; Okoniewski M; Reineke T; Tinguely M; Faggioni A; Trivedi P; Meister G; Renner C; Grässer FA
    Nucleic Acids Res; 2011 Mar; 39(5):1880-93. PubMed ID: 21062812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr Virus miR-BHRF1-3 Targets the BZLF1 3'UTR and Regulates the Lytic Cycle.
    Fachko DN; Chen Y; Skalsky RL
    J Virol; 2022 Feb; 96(4):e0149521. PubMed ID: 34878852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of a viral microRNA is regulated by clustering to allow optimal B cell transformation.
    Haar J; Contrant M; Bernhardt K; Feederle R; Diederichs S; Pfeffer S; Delecluse HJ
    Nucleic Acids Res; 2016 Feb; 44(3):1326-41. PubMed ID: 26635399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-18a reactivates the Epstein-Barr virus through defective DNA damage response and promotes genomic instability in EBV-associated lymphomas.
    Cao P; Zhang M; Wang L; Sai B; Tang J; Luo Z; Shuai C; Zhang L; Li Z; Wang Y; Li G; Xiang J
    BMC Cancer; 2018 Dec; 18(1):1293. PubMed ID: 30594162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAX1BP1 downregulation by EBV-miR-BART15-3p enhances chemosensitivity of gastric cancer cells to 5-FU.
    Choi H; Lee SK
    Arch Virol; 2017 Feb; 162(2):369-377. PubMed ID: 27757686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of Virus-Encoded MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma and Their Roles in Gastric Carcinogenesis.
    Shinozaki-Ushiku A; Kunita A; Isogai M; Hibiya T; Ushiku T; Takada K; Fukayama M
    J Virol; 2015 May; 89(10):5581-91. PubMed ID: 25740983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr Virus (EBV)-BamHI-A Rightward Transcript (BART)-6 and Cellular MicroRNA-142 Synergistically Compromise Immune Defense of Host Cells in EBV-Positive Burkitt Lymphoma.
    Zhou L; Bu Y; Liang Y; Zhang F; Zhang H; Li S
    Med Sci Monit; 2016 Oct; 22():4114-4120. PubMed ID: 27796281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation of the tumor suppressor gene PRDM1/Blimp-1 supports a pathogenetic role in EBV-positive Burkitt lymphoma.
    Zhang T; Ma J; Nie K; Yan J; Liu Y; Bacchi CE; Queiroga EM; Gualco G; Sample JT; Orazi A; Knowles DM; Tam W
    Blood Cancer J; 2014 Nov; 4(11):e261. PubMed ID: 25382611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Epstein-Barr virus miR-BHRF1-1 targets RNF4 during productive infection to promote the accumulation of SUMO conjugates and the release of infectious virus.
    Li J; Callegari S; Masucci MG
    PLoS Pathog; 2017 Apr; 13(4):e1006338. PubMed ID: 28414785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Viral microRNA Cluster Regulates the Expression of PTEN, p27 and of a bcl-2 Homolog.
    Bernhardt K; Haar J; Tsai MH; Poirey R; Feederle R; Delecluse HJ
    PLoS Pathog; 2016 Jan; 12(1):e1005405. PubMed ID: 26800049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis.
    Zhao CX; Yan ZX; Wen JJ; Fu D; Xu PP; Wang L; Cheng S; Hu JD; Zhao WL
    Mol Cancer; 2021 Dec; 20(1):153. PubMed ID: 34852843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Epstein-Barr virus miR-BHRF1 microRNAs regulate viral gene expression in cis.
    Poling BC; Price AM; Luftig MA; Cullen BR
    Virology; 2017 Dec; 512():113-123. PubMed ID: 28950226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-generation sequencing of miRNAs in clinical samples of Epstein-Barr virus-associated B-cell lymphomas.
    Sakamoto K; Sekizuka T; Uehara T; Hishima T; Mine S; Fukumoto H; Sato Y; Hasegawa H; Kuroda M; Katano H
    Cancer Med; 2017 Mar; 6(3):605-618. PubMed ID: 28181423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.